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1. INTRODUCTION 
Early miscarriage is a common experience for women and is 
responsible for the maximum number of pregnancy losses. 
Approximately one in four women will experience such a loss in her life 
time6. Local data shows an annual abortion rate of 3% in women aged 
between 15-49 years, in that incomplete and missed abortion being most 
common, occurs in approximately 15% of clinically recognized 
pregnancies  in 8,90,000 women per year4. 
While abortion is legally permitted in many countries, women 
continue to face profound barriers that restrict their access to safe 
abortion services and endanger their health. Lack of trained abortion 
providers, restrictions in service availability and high costs may all 
present obstacles too great for women to overcome in a timely manner. 
Maternal deaths due to unsafe abortion are around 10-13% in 
developing countries. Hence a method which is safe and cost effective 
has to be found. At present vacuum aspiration, sharp curettage, medical 
evacuation with misoprostol and expectant management are the 
available methods. Vacuum aspiration has come up as the most widely 
used method due to its safety and being less painful than dilatation and 
curettage (D&C) and medical methods. A high efficacy of vacuum 
  
aspiration with success rate between 95-100% has been reported in 
various trials of study in vacuum aspiration. 
MVA is being used since 1973 with good safety and efficacy 
reports around the world. Its use has been extended for the management 
of missed miscarriage and molar pregnancy. 
 Manual vacuum aspiration (MVA) can offer health care systems a 
safe, accessible, and affordable way to provide abortion and overcome 
barriers that inhibit women’s ability to access services. MVA has 
several benefits that make it a worthwhile component of abortion 
services. Compared to dilatation and curettage (D&C), MVA is a 
potentially less expensive way to offer a high-quality service to women 
throughout the world. Other methods are usually only done by doctors 
in medical centers, but MVA can be done by paramedics. If midwives 
and others learn to use MVA safely, more women, especially poor 
women and women who live in villages far from medical care will have 
access to safe abortions and to life-saving care after incomplete 
miscarriage and MTP. 
 
 
  
2. OVERVIEW 
INCIDENCE 
It is difficult to assess accurately the incidence of abortion, since 
many illegally induced abortions are not reported. Some very early 
abortion usually resemble delayed period.10% of all pregnancy end in 
spontaneous abortion and another 10% are induced illegally.75% of 
abortion occur before 16th week of pregnancy, of which 75% occur 
before the 8th week of pregnancy3. 
 
MECHANISM OF ABORTION 
Almost 80% of diagnosed abortions occur before the second 
trimester of pregnancy. 
Before 8 weeks: The pregnancy sac is extruded from the uterus in 
en mass. 
8-14 weeks: Expulsion of the fetus commonly occurs leaving 
behind the placenta and membranes causing brisk haemorrhage. 
Beyond 14 weeks: After that time the process resembles that of a 
labour in that, the membranes rupture at some stage during dilatation of 
  
cervix and the fetus and placenta born separately. As the uterus is not 
properly sensitized and its muscular action is less efficient, some part of 
the chorion is therefore often retained and excessive haemorrhage is 
common. 
 
PATHOLOGY OF ABORTION 
Haemorrhage into deciduas basalis and necrotic changes in the 
tissue adjacent usually accompany abortion. The ovum becomes 
detached and stimulates uterine contractions that result in expulsion. 
When the sac is opened, fluid is commonly found surrounding a small 
macerated fetus or alternatively, there may be no visible fetus in the sac, 
the so called blighted ovum. 
  
Blood or carneous mole is an ovum that is surrounded by a 
capsule of clotted blood. The small fluid containing cavity within 
appears compressed by thick walls of old blood clot. The retained fetus 
may undergo maceration. The bones of skull collapse and the abdomen 
becomes, distended with bloodstained fluid. The skin softens and peels 
off in utero. Internal organs degenerate and undergo necrosis. Amniotic 
fluid may be absorbed when the fetus becomes compressed upon itself 
and desiccated to form a fetus compressus. Occasionally the fetus 
  
eventually becomes so dry and compressed that it resembles parchment 
so called fetus  papyraceous. 
 
 
TYPES OF ABORTION 
 1) Spontaneous  
a)  Isolated    b) Recurrent  
 
 
 
Threatened, inevitable, complete, incomplete, and missed.  
 
2) Induced  
 
a) legal     b) illegal  
 
 
 
    Septic abortion  
 
    Fig :1 TYPES OF ABORTION 
 
  
CATEGORIES OF ABORTION 
 
 
1. Threatened abortion 
It is a clinical entity where the process of abortion has started but 
has not progressed to a state from which recovery is impossible. 
 
2. Inevitable abortion 
It is a clinical type of abortion where the change has progressed to 
a state from where continuation of pregnancy is not possible. 
Inevitability of abortion is signaled by gross rupture of membranes in 
the presence of cervical dilatation. 
 
3. Complete abortion 
When the products of conception are expelled en masse, it is 
called complete abortion. 
 
4. Incomplete abortion 
When the entire products of conception are not expelled, instead a 
part of it is left inside the uterine cavity, it is called incomplete abortion. 
 
5. Missed abortion 
When the dead fetus had been retained inside the uterus for more 
than four weeks, it is called missed abortion. 
  
6. Septic abortion 
Any abortion associated with clinical evidence of infection of 
uterus and its contents is called septic abortion. 
 
7. Habitual / recurrent abortion 
It is defined as three or more consecutive spontaneous abortions.  
 
DILATATION AND CURETTAGE 
Dilatation and curettage (D&C) for women undergoing early 
pregnancy failure is one of the most common procedures in gynecology. 
Traditional management of early pregnancy loss involves D&C under 
general anesthesia, often as an inpatient. This practice is based on 
protocols established more than a century ago, and although medicine 
has advanced enormously, miscarriage management has not. 
 For instance, despite the relatively common usage of the curette, 
it is associated with higher rates of uterine perforation, increased blood 
loss, and more frequent blood transfusions 5. 
In our study D&C was done under paracervical block or 
intravenous anesthesia depending upon the pain perception. The age 
distribution taken for study is equal in both groups. 
  
The average time taken was around 8 to 10minutes in both 
groups. In our study the type of anesthesia, procedure, and patient 
morbidity was observed in both groups. All patients were followed up 
after 14 days with USG. 
 
MANUAL VACUUM ASPIRATION 
MVA offers a safe, effective, accessible and low-cost way to 
overcome barriers that hamper women’s access to abortion services. 
MVA can be performed in typical clinical settings and as an outpatient 
procedure without the need for operating room facilities. MVA does not 
require electricity, and may be performed by such as midwives, nurse 
practitioners and physician assistants. Though D&C was once the 
standard of care it is still used in many centers. These qualities of MVA 
can help shift abortion services to community based health care settings, 
which not only decreases costs but also expands access to services. A 
World Health Organization Technical Working Group has listed 
vacuum aspiration as an essential element of care at the first-referral 
level (WHO, 1991). 
  
  Trained health care personnel around the world have used 
MVA technology to improve the quality of abortion care in diverse 
settings. MVA can also be used to perform menstrual regulation, treat 
incomplete abortions, perform endometrial biopsies and back-up failed 
abortions that were performed by either surgical or medical methods. 
This method has the capacity to dramatically expand women’s access to 
abortion services. In remote areas, MVA may be the difference between 
safe and effective abortion services and no services at all. MVA can be 
extremely effective in improving the accessibility of high-quality 
abortion services at all levels of the health system. MVA plays a very 
important role in effective abortion care that is acceptable to women and 
responds to their needs—that is, care that can truly make a difference in 
improving women’s health. 
 
MVA SAFETY AND EFFICACY 
MVA has been demonstrated to be effective and safe through 
clinical studies over the last 30 years for early elective abortion and 
management of early pregnancy loss. The World Health Organization 
(WHO) recommends MVA as a preferred method of uterine evacuation. 
When compared to sharp curettage (also known as dilation and curettage 
  
or D&C), MVA is a safer, more readily accessible, and potentially less 
expensive way to offer high-quality services to women. The efficacy of 
MVA is comparable to D&C and is successful in approximately 99% of 
cases. 
 
INDICATIONS FOR MVA USE 
MVA also can be used for any indication that requires suction. 
Evacuation of the uterus, including 
 Early miscarriage. 
 MTP less than 12 weeks 
 Back up for failed medical abortion6 
Early miscarriage 
MVA can be used successfully in early miscarriage with almost 
nil complications. 
MTP less than 12 weeks 
The efficacy of MVA in completion rates in most studies is 
almost 98% .Since women can make a decision about their pregnancy as 
early as three or four days after a missed period, we should provide safe 
  
and effective options in early pregnancy which increases the 
opportunities for women to access desired care 
Back up for Failed Medical Abortion 
Aspiration is sometimes necessary for management of a 
continuing pregnancy despite the success rate of 95% in medical 
abortion using modern regimens of mifepristone and misoprostol. Thus 
MVA offers an alternative to D & C to manage this situation. 
 
INVESTIGATIONS NEEDED IN CASE OF ABORTION 
1. Blood Hemoglobin, Total count and Differential count. 
2. Blood Grouping and Rh typing 
3. Blood Sugar-fasting and Postprandial 
4. VDRL, HIV, HBsAg 
5. Urine –Routine and Microscopy. 
6. Special investigation: USG 
 
 
 
 
  
COMPONENTS OF MVA PROCEDURE 
  
MVA Instruments6 
 
 
 
 
 
 
 
  Aspirator 
  lubricant 
 Cannula (4–12 mm) 
 Adaptor for cannula 
 Speculam 
 Tenaculum (sharp-toothed or atraumatic) 
  Antiseptic solution, gauze, and small bowl. 
  Dilators of various size. 
 Local anesthesia for cervical block6 
One part is a 50 cc syringe with a wide opening that creates a 
vacuum to pull the contents of the womb out8  
  
 
Fig 2: Parts of MVA 
The other main part of the kit is a set of plastic tubes called 
cannulas. One end of the cannula will be attached to the syringe. The 
other end will be put inside the womb. 
 
Fig 3: Different Sizes of MVA Cannula 
  
 Cannulas come in many different sizes (the size may be printed 
on it). The larger a woman’s womb is, the larger a cannula you should 
use. This chart gives you an idea of which cannula might work  best8 
  
 
 
Fig 4: Measurements of Cannula 
 
PAIN MANAGEMENT IN MVA 
Surgical abortion in the first trimester are done under local 
anesthesia (para cervical block). Appropriate local anesthetic in the 
cervix can reduce pain associated with the procedure and also the 
inpatient admissions. Intravenous anesthesia proves patient satisfaction 
but does not significantly affect pain scoring2.  
MVA allows a lower level of pain control medication than sharp 
curettage. Cervical block which has been proven to be very safe for use 
in abortion procedures can be effectively used in conjunction with 
analgesics for pain control during MVA. Cervical block reduces 
  
recovery time and requires fewer expenses for personnel, infrastructure 
and equipment. 
In contrast, the D&C procedure is typically performed with 
general anesthetic or heavy sedation which is expensive and also general 
anesthesia is associated with an increased complications from blood 
loss, cervical injury, uterine perforation and subsequent abdominal 
hemorrhage. Heavy anesthesia also places a strain on the health care 
system, as it requires more complicated facilities and equipment. In 
many countries, reliance upon general anesthesia limits the settings in 
which surgical abortions can be performed. 
The patient’s reduced perception of pain with MVA is 
particularly notable in comparison with the D&C procedure. Reducing 
pain also lessens the patient’s anxiety and fear, thereby improving her 
overall satisfaction with the procedure. By allowing pain to be 
effectively managed with cervical block, analgesics and verbal support, 
MVA lowers costs, improves safety, enhances patient satisfaction and 
expands service availability. In our study pain is scored using visual 
analogue scale (fig 5). 
 
  
Edelman (Edelman 2001) found that both, pain and duration of 
operation may be less with more experienced operators. D&C continues 
to be used in many countries. The statistically significant reduction 
operating time with vacuum aspiration (1.8minutes) compared to D&C 
may be of importance for women undergoing the operation under local 
anaesthesia.  
 
Fig 5: Visual Analogue Scale 
  
 
Cervical Block Given at 3 & 9’ clock position 
 
DILATATION OF THE CERVIX 
 
Dilatation of cervix is done according to the gestational age. 
Excessive dilatation of the cervix can cause cervical or uterine injury 
which is not required in MVA compared to D&C6.  
OPERTATIVE STEPS 
1. Injection local anesthesia was injected in the cervix7 
2. Vacuum was created in 60 ml double valve MVA syringe. 
 Close the valve by pushing the button inward and forward. 
The button will make a “click” sound and will stay stuck in 
place until you open itagain8 
  
  
Fig 6: Doing the MVA 
 Hold the barrel of the syringe with one hand and pull the 
plunger back with the other hand, until the arms of the 
plunger snap outward at the end of the syringe barrel. 
Check the arms of the plunger. They should both be out as 
far as they can go. With the arms snapped in this position, 
you should not be able to push the plunger back into the 
barrel8 
1. The uterus was re-evaluated by bimanual examination. 
2. Cervix is cleansed by antiseptic lotion and paracervical block/IV 
anesthesia is given. 
3. The size of the cannula is selected (varying from 4mm – 12mm) 
to snugly fit in the cervical canal. 
  
4. Using no touch technique the cannula is inserted through the 
cervix towards the fundus. 
5. The syringe is attached to the canula and the pinch valves 
released allowing the vacuum to get transferred to the uterine 
cavity. 
6. Contents of the uterus were evacuated by using rotatory or back 
and forth movements of the cannula. 
7. Appearance of foam or bubbles, absence of more products getting 
aspirated, a gritty sensation as the cannula passes over the uterine 
walls, and a feel of the uterus contracting around the cannula were 
considered as signs of completeness of the procedure.  
8.  Inspection of chorionic villi is done after evacuation. The 
average time taken for the procedure was 8 minutes with a 
maximum of 10 minutes. All Patients were discharged after 2 
days after advising an oral antibiotic and an analgesic.  All of 
them were given family planning advice and follow up scan was 
done after 14 days. 
  
CONTRAINDICATIONS AND CAUTION IN USE OF 
MVA 
 
There are no contraindications for MVA when used for MTP up 
to 12 weeks of gestation. When MTP is done using MVA between 8 -12 
weeks, it may require emptying of syringe barrel 2 or more times to 
complete the procedure. .Alternatively, multiple syringes may be used in 
succession 6. 
  
MVA should not be used for endometrial biopsy in the case of suspected 
pregnancy and should be used with caution in women who have: 
 
• Anomalies of uterus. 
• Blood dyscrasias. 
• Acute pelvic infection. 
• Extreme anxiety. 
• Life-threatening medical conditions must be addressed and 
managed before uterine aspiration, regardless of the vacuum 
source.6 
 
  
POSSIBLE MVA COMPLICATIONS 
 MVA used for MTP is associated with an overall complication 
rate of about 2%, the majority of which required re aspiration and 
perforation. The most important part in MTP procedure is diagnosing 
complication.6 
 
• Incomplete evacuation By examining the products of conception 
the completeness of procedure can be confirmed. Incomplete 
evacuation can be treated by repeating the uterine aspiration.6 
• Uterine perforation This type of complication can be avoided by 
careful assessment of gestational age and position of 
cervix.Uterine perforation is most commonly seen in D&C. 
• Cervical laceration 
• Pelvic infection 
• Hemorrhage excessive bleeding is rare but can occur following 
MVA.  
• Hematometra This condition can be treated by re-aspirating the 
uterus, although dilatation alone is often sufficient6 
• Vagal reaction This usually occurs near or after completion of the 
procedure. Women usually feel giddiness or nausea. Stop the 
procedure until the reaction has ceased. Then made to lie either 
  
flat or in reverse Trendelenburg with her feet raised above the 
level of her heart. Once the reaction has subsided, continue the 
procedure.6 
CONTROLLING INFECTION 
  
Using of a no-touch technique and antibiotics can help to avoid 
infection.  
POST PROCEDURE PATIENT MONITORING 
After the procedure the patient was monitored for vitals, urine 
output, sign of excessive bleeding and abdominal pain. USG was done 
immediately and after 2 days to look for retained products and if any 
then repeat procedure was done.6 
TISSUE EXAMINATION 
The products of conception(POC) is examined to confirm the 
completeness of procedure. For very early gestations, POC are less 
likely to be disrupted during the aspiration when using MVA as 
compared to D&C. Lack of complete POC identification may indicate 
an ongoing or ectopic pregnancy6.  
  
MANUAL VACCUM ASPIRATION:  
SERVICE DELIVERY 
Doctors appreciate the simplicity, portability and cost-
effectiveness of MVA. Any doctors who engages in gynecological 
services is probably well equipped to provide MVA. The instruments do 
not require electricity, and providers at various levels of the health care 
system can safely perform MVA.  
MVA is easy to use in a variety of settings, including first-referral 
level sites, primary care facilities, medical offices and clinics. Its 
simplicity helps move abortion services out of hospital and operating 
room settings where D&C is typically performed. 
MVA also allows doctors to offer women safe and effective 
abortions in a private office or when the operating theater is booked, 
reducing delays and decreasing the number of staff required for the 
procedure. 
The burden on health care systems is reduced when a doctors is 
able to perform an abortion at the time the woman presents at the 
facility, rather than waiting for physicians and operating rooms to 
become available as in case of D&C. MVA makes safe abortions 
  
possible in low-resource or remote areas, particularly where other 
methods are not feasible.  
 
EQUIPMENT AND PERSONNEL COSTS 
 
MVA is a relatively inexpensive service to provide. Reusing the 
MVA aspirator after disinfection or sterilization helps reduce costs. 
Even when limited to single-use additional savings are realized when 
abortion services are moved out of the operating theater or emergency 
room, reducing expenditures for anesthesia, hospital infrastructure, 
sterile supplies and patient recovery care. 
 
Because of MVA’s effectiveness, many patients do not require a 
follow-up visit and many women, particularly those in rural areas, do 
not find it feasible to return for a second visit. Some clinics, however, 
require or encourage patients to return for a follow-up exam to confirm 
that there are no complications and that the procedure was successful. 
 
  
CONTRACEPTIVE COUNSELLING 
Contraceptive counseling is another essential component of 
patient-centered abortion care. A woman seeking an abortion does so 
because she does not want to be pregnant at that time; she may want to 
avoid childbearing for the immediate future, if not longer. Pregnancy 
can occur almost immediately after abortion. The abortion procedure 
therefore offers a convenient opportunity for women to receive 
contraceptive information and services. The brief recovery period after 
MVA/D&C is an apt time to discuss contraception with patients. 
Contraceptive counseling and care can be integrated into abortion 
services regardless of whether the procedure is performed in a doctor’s 
office, hospital setting, and clinic or community health center. What 
matters most is that the patient leaves with information and methods she 
can use to prevent further unwanted pregnancies. 
  
3. REVIEW OF LITERATURE 
  
K. Mahomed J. Healy S. Tandon 
A prospective longitudinal study was carried out in two Harare 
Hospitals to determine whether Manual Vacuum Aspiration (MVA) 
was as safe and as effective as sharp curettage for treatment of 
incomplete abortion. Based on procedure-related complications at the 
time of treatment, MVA was found to be as safe as sharp curettage in 
treating incomplete abortion ≤ 12 weeks gestation. MVA was more 
effective than sharp curettage in achieving complete uterine evacuation 
(0% incomplete evacuation vs. 0.7%, P < 0.05)9. Our study also proves 
the same. 
Am J Obstet Gynecol 2000 : 183 : S76-S83 
“Surgical abortion by vacuum aspiration is one of the most 
commonly reported surgical procedures in the United States”. Manual 
vacuum aspiration with a handheld syringe safely accomplishes early   
 abortion in a variety of settings, from elective abortion in the office or 
clinic setting to emergency care of a patient with an incomplete 
abortion2. 
 
 
  
 According to the study by P.D. Blumenthal R.E. Remsburg 
Traditionally, management of incomplete abortion involves use of D&C 
or suction curettage in the operating room. Such management is costly 
and time- consuming. In order to potentially save time and money, they 
studied the use of Manual Vacuum Aspiration Curettage (MVAC) for 
the management of this procedure. The results were compared.  
MVA procedures resulted in significant savings in terms of both 
waiting times and costs. Waiting time was reduced by 52% and 
procedure time was reduced from a mean of 33 min to 19 min (P < 
0.01). Total hospital costs were reduced by 41%(P<0.01).So they 
concluded that the use of manual vacuum aspiration curettage in the 
management of incomplete abortion can reduce hospital costs and save 
time for both patients and clinicians. In our study there is no significant 
difference in time taken by both procedures. 
An article by k.Rogo  reviews the technologies used to diagnose 
pregnancy and manage abortion in developing countries. The author 
discusses methods of diagnosing pregnancy including physical 
examination, laboratory and home testing, and ultrasound as methods 
for performing safe abortions. Due to manual vacuum aspiration  
(MVA) advances, vacuum aspiration has become safer and more 
  
feasible in low-resource settings. The author stresses the importance of 
post-abortion care and post-abortion contraception and, in the 
conclusion, identifies six areas in which technology can reduce 
abortion-related morbidity and mortality: pregnancy prevention, early 
diagnosis of pregnancy, accurate assessment of gestation, 
standardization and supply of MVA technology, and simple and 
affordable regimens for medical abortion. 
The study conducted by Greenslade et al., 1993b; Freedman et al., 
1986; Cates and Grimes, 1981 says the complication rates for abortions 
conducted by paramedics appear to be lower than those reported in 
studies in which physicians performed the abortion19 
Focus Group, 1998 says Midwives and other medical staff are 
now trained to perform MVA, making services more widely available 
and lessening the burden on physicians and hospitals. 
Verkuyl 1993 reviews data from two studies (involving 550 
women) where vacuum aspiration was compared to sharp metal 
curettage. Uterine perforation and need for re-evacuation were evaluated 
by both trials. The remaining outcomes (sepsis, pain, blood loss, post 
operative hemoglobin levels, duration of procedure and duration of 
bleeding) were evaluated by only one trial. Vacuum aspiration was 
  
associated with decreased blood loss and fewer women with blood loss 
greater than or equal to 100 ml, risk ratio (RR) 0.28, 95%CI 0.10 to 
0.73; and fewer women with a post-operative hemoglobin level less than 
10 g/dl (RR 0.55). Fewer women undergoing vacuum aspiration 
reported moderate to severe pain during the procedure (RR 0.74), and 
the duration of the procedure was shorter for vacuum aspiration than for 
sharp metal curettage. The remaining findings were not statistically 
significant. For vacuum aspiration versus sharp curettage respectively, 
the results were as follows: uterine perforation 0/227 versus 1/221 (RR 
0.32) need for re-evacuation3/227 versus 2/236 (RR 1.50) , incidence of 
sepsis 2/138 versus 7/132 (RR 0.27).  
The results indicate that vacuum aspiration is safe, quicker to 
perform, and less painful than sharp curettage, as evidenced by 
statistically significant findings of decreased blood loss, decreased 
perception of pain, and a shorter duration of the vacuum aspiration 
procedure. Uterine perforation is a serious complication of surgical 
evacuation procedures which is relatively rare with either of the 
approaches. Of more than 200 patients included in each arm, perforation 
occurred in one case in the sharp curettage group, and none in the 
vacuum aspiration group. There were few cases that required re-
  
evacuation in either group of both trials. Given the rare occurrence of 
perforation and need for re-evacuation with either approach, very large 
trials would be needed to evaluate any significant differences between 
vacuum aspiration and sharp curettage44.In our study blood loss was 
comparatively less in patients who underwent MVA, also the Pain score 
was also less in MVA group. 
Milingos 2009 says” Vacuum aspiration can be performed 
without the need for a fully equipped and staffed operating theatre as it 
can be done with or without electricity, under local anesthesia or 
sedation32.” 
 A recent observational study has also concluded that manual 
vacuum aspiration could be routinely considered to treat incomplete 
miscarriage, thus avoiding the need for general anesthesia and access to 
operating theater. It can therefore be performed in settings with limited 
resources, saving time and money, and possibly minimizing 
complications. Eliminating the need for transport to a better equipped 
facility might decrease the severity of an infection, or decrease blood 
loss and the subsequent need for transfusions. 
In conclusion, the results of this review suggest that vacuum 
aspiration is at least as effective as sharp curettage, if not more effective 
  
in the management of incomplete miscarriage. However, sharp curettage 
continues to be used widely in many parts of the world. Some clinicians 
argue that in experienced hands it is safe and effective and are therefore 
reluctant to change to suction curettage. 
Surgical procedures for evacuating incomplete miscarriage 
(Review) 6 Says Manual vacuum aspiration is also well accepted for 
surgical uterine evacuation in low-income settings, as illustrated in a 
review of 10 major post abortion care projects conducted in Latin 
America in the period 1991–2002.  
Greenslade 1993 conducted a study in Ghana in 2007 revealed that 
despite consensus about the serious need for the merit the change to this 
technology as been suggested that vacuum aspiration is more cost 
effective than sharp curettage. 
To address the harmful health consequences of unsafe abortion, a 
post abortion care model was developed in 1994. The model lists three 
essential elements:  
1. Emergency treatment for complications of spontaneous or 
induced abortion; 
2. Post abortion family planning counselling and services; 
  
3. Linkage between emergency care and other reproductive health 
services, such as management of sexually transmitted diseases.  
The post abortion care model has been implemented in many 
countries with restrictive abortion laws as a means to address the 
complications associated with unsafe abortion. When focusing on 
emergency treatment for abortion complications, manual vacuum 
aspiration (MVA) is considered a cost-effective alternative to standard 
surgical curettage, which is often used for emergency care in low-
income settings. 
The efficacy of MVA has been assessed in a retrospective 
Scottish study, which reported the efficacy of the procedure to be 94.7% 
among 245 patients undergoing MVA for incomplete abortion. 
 A meta-analysis has also measured the safety, efficacy and 
acceptability of MVA in comparison with electric vacuum aspiration. 
There was no significant difference in complete abortion rate and 
participants’ satisfaction, whereas the operation time was shorter for  
vacuum aspiration. 
The need for re-evacuation was slightly lower in the vacuum 
aspiration group by Tan 1969. 
  
In a large multicentre cohort study, data from over 4400 women 
undergoing first trimester vacuum aspiration or D&C were analysed. 
The total complication rate varied with the gestational age and the 
method used. Vacuum aspiration was associated with lower rates of 
complications at 9 to 12 weeks when compared to D&C. Major 
complication rates such as excessive blood loss, uterine injury, 
prolonged bleeding and repeat curettage and pelvic infection were 
higher in both groups with increased gestational age. 
Edelman (Edelman 2001) 
“Found that both, pain and duration of operation may be less 
with more experienced operators. D&C continues to be used in many 
countries. The statistically significant reduction in operating time with 
vacuum aspiration (1.8minutes) compared to D&C may be of 
importance for women undergoing the operation under local 
anaesthesia. Hand-held syringes for MVA are inexpensive, require little 
maintenance and can be the method of choice for early surgical 
abortion in resources trained settings”. Bird 2003. The Cochrane 
Collaboration. Published by  JohnWiley & Sons, Ltd. 
 
  
SAFETY AND EFFICACY OF MVA5 
 
STUDY 
 
 
DESIGN 
 
DIAGNOSIS 
 
TREATMENT 
 
CONTROL 
 
CONCLUSIONS 
 
Mahomed 
et al. 
(1994) 
 
Cohort 
 
Incomplete 
abortions 
 
MVA under 
local (n=589) 
 
Sharp 
curettage 
with general 
anesthesia 
(n=589) 
 
Equal safety and 
effectiveness of 
MVA. 
Lukeman 
and 
Pogharian 
(1996) 
Case-control Incomplete 
abortions 
 
MVA (n=432) Sharp 
Curettage 
(n=869) 
Equal safety and 
effectiveness of 
MVA. 
Verkuyl 
and 
Crowther 
(1993) 
Randomized 
controlled 
trial 
Incomplete 
abortions 
MVA (n=179) Sharp 
Curettage 
(n=178) 
MVA had lower 
rate of excessive 
bleeding 
 
MVA was shorter 
procedure 
De Jonge 
et al. 
(1994) 
Randomized 
controlled 
Incomplete 
abortions 
MVA (n=73) Sharp 
Curettage  
(n=68) 
MVA group had 
fewer transfusions 
than the sharp 
curettage group 
(17% vs 35%) 
 
Kizza and 
Rogo 
(1990) 
 
Cohort 
 
Incomplete 
abortions 
 
MVA (n=300) 
 
Sharp 
Curettage 
(n=285) 
 
Equal safety and 
effectiveness of 
MVA (incomplete 
evacuation) 
 
Hemlin 
and 
Moller 
(2001) 
Randomized  Induced 
abortion 
MVA (n=99) Electric 
Vacuum 
(n=98) 
MVA and EVA 
had equivalent 
efficacy and safety 
Westfall et 
al. (1998) 
Retrospective Induced 
abortion 
MVA (n=1677) None MVA was 99.5% 
effective. 
Postoperative 
infections 
infrequent (0.5%) 
and rare uterine 
perforations 
(0.05%) 
  
4. AIM OF STUDY 
 
To compare the efficacy of manual vacuum aspiration against  
curettage in first trimester incomplete abortion in terms of type of 
anesthesia, procedure, and patient morbidity pattern. 
ANESTHESIA: The type of anesthesia used is either cervical block or 
intravenous anesthesia depending upon pain perception by the patient. 
PROCEDURE: The procedure done for induced abortion is either 
manual vacuum aspiration or curettage. The efficacy of these two 
procedures is compared in terms of blood loss, blood transfusion, 
retained products, repeat procedure. 
PATIENT MORBIDITY: Patient’s morbidity is compared in terms of, 
complications like cervical laceration, uterine perforation, stay in 
hospital for more than two days. 
STUDY DESIGN 
Our study is a case control study conducted at Institute of Social 
Obstetrics, Govt. Kasturba Gandhi Hospital, Chennai between the 
period September 2010 –and September 2011. 
  
5. MATERIALS AND METHODS 
 
All women seeking MTP for incomplete abortion in our hospital 
between September 2010 - September 2011 were admitted. 
In these women who belonged to first trimester was taken for our 
study. Our sample size (CASES) was 100, who underwent manual 
vacuum aspiration was compared with 100 CONTROLS who were 
offered curettage . 
INCLUSION CRITERIA 
 
• All pregnant women seeking MTP for incomplete abortion whose 
age was < 35 yrs. 
• Women who  stayed near by the hospital for easy access 
• Who can come for follow up. 
EXCLUSION CRITERIA 
1. Patients with medical complications like  uncontrolled 
hypertension, diabetes. 
2. Blood dyscrasias, heart disease. 
3. All MTPs attempted outside our institution. 
4. Patients with evidence of sepsis. 
 
  
6. ANALYSIS OF RESULT 
 
TYPE OF ANAESTHESIA USED 
TABLE 1 
 
 MVA/CURETTAGE 
1 2 Total 
Anaesthesia cervical 
block 
Count 89 66 155 
% within MVA/CURETTAGE 89.0% 66.0% 77.5% 
% of Total 44.5% 33.0% 77.5% 
IV Count 11 34 45 
% within MVA/CURETTAGE 11.0% 34.0% 22.5% 
% of Total 5.5% 17.0% 22.5% 
 Total Count 100 100 200 
% within MVA/CURETTAGE 100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
This table indicates the type of anesthesia used for both cases and 
controls. 
    
 
 
 
 
 
  
CHI-SQUARE TESTS 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 15.168a 1 .000   
Continuity 
Correctionb 
13.878 1 .000 
  
Likelihood Ratio 15.755 1 .000   
Fisher's Exact Test    .000 .000 
N of Valid Cases 200     
 
 Chi square -15.168, and p< .000 which is significant  
 
TABLE 1 
This table indicates the type of anesthesia used for both cases and 
controls. 
Out of the 100 patients in cases 89% was given cervical block 
compared to control group which is 66%. In control out of 100 patients 
34% of patients needed intra venous anesthesia. The p value is < 0.000 
which is significant and chi square is 15.168. 
 
 
 
  
CHART : 1 
 
 
 
This bar  diagram represent the percentage of cervical block and 
intravenous anesthesia used in cases and controls. 
 
  
 
Blood  LOSS - PADS USED /DAY 
      TABLE 2 
 MVA/CURETTA
GE N Mean Std. Deviation Std. Error Mean 
Blood Loss 
PAD/DAY 
1 100 3.32 1.348 .135 
2 100 3.95 1.274 .127 
 
 TABLE 2 
This table shows the average no of pads used by both cases and 
controls. The no of pads used per day was more in controls (3.95) than 
the cases (3.32) .  
 
INDEPENDENT SAMPLES TEST 
 
Levene's Test for 
Equality of Variances 
t-test for Equality of 
Means 
F Sig. t df 
Blood Loss 
PAD/DAY 
Equal variances 
assumed 
1.279 .260 -3.397 198 
Equal variances not 
assumed 
  
-3.397 197.385 
 
 
  
 
 
INDEPENDENT SAMPLES TEST 
 t-test for Equality of Means 
Sig. (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
Blood Loss 
PAD/DAY 
Equal variances assumed .001 -.630 .185 
Equal variances not 
assumed 
.001 -.630 .185 
 
The p value is .001 which is significant.  
 
 
INDEPENDENT SAMPLES TEST 
 t-test for Equality of Means 
95% Confidence Interval of the 
Difference 
Lower Upper 
Blood Loss PAD/DAY Equal variances assumed -.996 -.264 
Equal variances not assumed -.996 -.264 
 
 
  
 
 
 
 
 
CHART: 2 
 
This bar diagram represents the average no of pads used by cases 
and controls. 
 
 
 
  
 
 
BLOOD TRANSFUSION 
TABLE 3 
 MVA/CURETTAGE 
1 2 Total 
Blood 
Transfusion 
no Count 96 88 184 
% within 
MVA/CURETTAGE 
96.0% 88.0% 92.0% 
% of Total 48.0% 44.0% 92.0% 
yes Count 4 12 16 
% within 
MVA/CURETTAGE 
4.0% 12.0% 8.0% 
% of Total 2.0% 6.0% 8.0% 
Total Count 100 100 200 
% within MVA/CURETTAGE 100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
This table compares the amount of blood transfused in both cases 
and controls. 
 
  
 
CHI-SQUARE TESTS 
 
The chi square is 4.348, and p value is < .037 which is significant. 
TABLE 3 
It indicates that the no of blood transfusion is more in controls 
(12%) compared to cases. (4%).The p value is <0.037 which is 
significant.  
 
 
 
 
 
 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-
Square 
4.348a 1 .037 
  
Continuity 
Correctionb 
3.329 1 .068 
  
Likelihood Ratio 4.534 1 .033   
Fisher's Exact Test    .065 .033 
N of Valid Cases 200     
  
 
 
 
CHART : 3 
 
 
This bar diagram represents the number of blood transfusion given 
in cases and control group. 
 
 
  
 
 
PERCENTAGE OF RETAINED PRODUCTS 
TABLE 4 
 MVA/CURETTAGE 
1 2 Total 
Retained 
Products 
No Count 82 58 140 
% within 
MVA/CURETTAGE 
82.0% 58.0% 70.0% 
% of Total 41.0% 29.0% 70.0% 
Yes Count 18 42 60 
% within 
MVA/CURETTAGE 
18.0% 42.0% 30.0% 
% of Total 9.0% 21.0% 30.0% 
Total Count 100 100 200 
% within 
MVA/CURETTAGE 
100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
This table shows the percentage of patients who had retained 
products in cases and controls. 
 
 
 
  
 
 
CHI-SQUARE TESTS 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 13.714a 1 .000 
  
Continuity 
Correctionb 
12.595 1 .000 
  
Likelihood Ratio 14.009 1 .000 
  
Fisher's Exact Test 
   
.000 .000 
N of Valid Cases 200     
chi square is 13.714,p value is .000 which is significant 
 
TABLE 4 
The % of retained products is more in controls (42%) than in cases 
(12%). The p value is<0.000 which is significant.  
 
 
 
 
  
 
 
CHART : 4 
 
 
This bar diagram represents the number of patients who had 
retained products in cases and control group. 
 
 
 
  
 
 
REPEAT PROCEDURE 
TABLE 5 
 MVA/CURETTAGE  
1 2 Total 
Repeat Procedure no Count 92 79 171 
% within 
MVA/CURETTAGE 
92.0% 79.0% 85.5% 
% of Total 46.0% 39.5% 85.5% 
yes Count 8 21 29 
% within 
MVA/CURETTAGE 
8.0% 21.0% 14.5% 
% of Total 4.0% 10.5% 14.5% 
Total Count 100 100 200 
% within 
MVA/CURETTAGE 
100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
This table shows the percentage of patients who needed repeat 
procedure. 
 
 
 
  
CHI-SQUARE TESTS 
 
Value Df 
Asymp. Sig. 
(2-sided) 
Exact Sig. 
(2-sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 6.816a 1 .009   
Continuity Correctionb 5.808 1 .016   
Likelihood Ratio 7.030 1 .008   
Fisher's Exact Test    .015 .007 
N of Valid Cases 200     
Chi square is 6.816 and  p is < 0.009 which is significant. 
TABLE 5 
The repeat procedure was more in controls (21%) than in cases is 8%. 
CHART :5 
 
This bar diagram represents the number of patients who needed 
repeat procedure in both cases and control group. 
  
 
STAY IN HOSPITAL   
TABLE 6 
 MVA/CURETTAGE 
1 2 Total 
Stay in Hospital 1 Count 91 76 167 
% within 
MVA/CURETTAGE 
91.0% 76.0% 83.5% 
% of Total 45.5% 38.0% 83.5% 
2 Count 9 24 33 
% within 
MVA/CURETTAGE 
9.0% 24.0% 16.5% 
% of Total 4.5% 12.0% 16.5% 
Total Count 100 100 200 
% within 
MVA/CURETTAGE 
100.0% 100.0% 100.0% 
% of Total 50.0% 50.0% 100.0% 
 
This table shows the percentage of people who stayed more than 2 days 
in the hospital. 
 
 
 
 
  
 
 
CHI-SQUARE TESTS 
 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. 
(1-sided) 
Pearson Chi-Square 8.165a 1 .004   
Continuity Correction 7.113 1 .008   
Likelihood Ratio 8.424 1 .004   
Fisher's Exact Test    .007 .003 
Linear-by-Linear 
Association 
8.125 1 .004 
  
N of Valid Cases 200     
chi square is 8.165,p is .004 which is significant 
TABLE 6 
The stay in hospital for >than 2 days is more in controls is (24%) 
than in cases (9%). The p value is 0.004 which is significant 
 
 
 
  
 
 
CHART:6 
 
 
This bar diagram represent the percentage of patients who  stayed  
more than 2 days in cases and control group. 
 
 
 
 
 
 
 
 
  
 
 
 
CERVICAL   LACERATION 
TABLE 7 
   MVA/CURETTAGE  
   1 2 Total 
cervical laceration  
 
No Count 100 88 188 
% within 
MVA/CURETTAGE 
100.0% 88.0% 94.0% 
 Yes Count 0 12 12 
% within 
MVA/CURETTAGE 
.0% 12.0% 6.0% 
Total Count 100 100 200 
% within 
MVA/CURETTAGE 
100.0% 100.0% 100.0% 
 
This table compares the percentage of patients who had cervical 
laceration in both cases and controls. 
 
 
  
 
 
  
 
CHI-SQUARE TESTS  
 
 
Value df 
Asymp. Sig. 
(2-sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 12.766a 1 .000   
Continuity Correction 10.727 1 .001   
Likelihood Ratio 17.402 1 .000   
Fisher's Exact Test    .000 .000 
N of Valid Cases 200     
 
chi square is 12.766, p is .000 which is significant 
TABLE 7 
 The cervical laceration is 12% in controls compared to cases which is 
0%. The p value is<0.000 which is significant. 
 
 
 
 
  
 
 
CHART : 7 
 
This pie chart shows the percentage of cervical laceration in cases 
(0%) and controls (12%). 
  
 
 
HEMOGLOBIN PRE AND POST PROCEDURE 
TABLE 8 
 
 Mean N Std. Deviation Std. Error Mean 
Pair 
1 HEMOGLOBINPRE 8.7440 200 .32324 .02286 
 HEMOGLOBINPOST 8.6610 200 .34244 .02421 
This table indicates the mean hemoglobin in both cases and controls 
 
Paired Samples Correlations 
  
N Correlation Sig. 
Pair 1 HEMOGLOBINPRE & 
HEMOGLOBINPOST 
200 .928 .000 
 
 
 
 
 
 
 
  
 
 
PAIRED SAMPLES TEST 
 
  
Paired Differences 
  
 
95% Confidence Interval of the 
Difference 
  
Mean 
Std. 
Deviation 
Std. Error 
Mean Lower Upper 
Pair 1  
HEMOGLOBINPRE – 
HEMOGLOBINPOST 
.08300 .12804 .00905 .06515 .10085 
 
PAIRED SAMPLES TEST 
 
  t df Sig. (2-tailed) 
Pair 1 HEMOGLOBINPRE – 
HEMOGLOBINPOST 
9.168 199 .000 
 
  
  
MVA  DATA 
 
PAIRED SAMPLES STATISTICS 
 
  Mean N Std. Deviation Std. Error Mean 
Pair 1 HEMOGLOBIN PRE 8.6830 100 .27526 .02753 
HEMOGLOBIN POST 8.6410 100 .29305 .02930 
 
This table indicates the mean hemoglobin pre procedure and post 
procedure in cases. 
 
PAIRED SAMPLES CORRELATIONS 
  N Correlation Sig. 
Pair 1 HEMOGLOBINPRE & 
HEMOGLOBINPOST 
100 .952 .000 
 
This table indicates the correlation between pre and post procedure 
in cases. 
  
 
PAIRED SAMPLES TEST 
 
  Paired Differences 
  
 
95% Confidence Interval of 
the Difference 
  
Mean 
Std. 
Deviation 
Std. Error 
Mean Lower Upper 
Pair 1 HEMOGLOBINPRE – 
HEMOGLOBINPOST 
.04200 .09010 .00901 .02412 .05988 
 
 
PAIRED SAMPLES TEST 
   
  
 
  t df Sig. (2-tailed) 
Pair 1 HEMOGLOBINPRE – 
HEMOGLOBINPOST 
4.662 99 .000 
 
 
 
 
 
  
 
CURETTAGE 
PAIRED SAMPLES STATISTICS 
  Mean N Std. Deviation Std. Error Mean 
Pair 1 HEMOGLOBIN PRE 8.8050 100 .35601 .03560 
HEMOGLOBIN POST 8.6810 100 .38604 .03860 
 
This table indicates the mean hemoglobin pre procedure and post 
procedure in controls. 
 
 
 
PAIRED SAMPLES CORRELATIONS 
  N Correlation Sig. 
Pair 1 HAEMOGLOBIN PRE & 
HAEMOGLOBIN POST 
100 .925 .000 
 
This table indicates the correlation between pre and post procedure 
in controls. 
  
PAIRED SAMPLES TEST 
 
  Paired Differences 
  
 
95% Confidence Interval of the 
Difference 
  
Mean 
Std. 
Deviation 
Std. Error 
Mean 
Lower Upper 
Pair 1 HAEMOGLOBINPRE – 
HAEMOGLOBINPOST .12400 .14642 .01464 .09495 .15305 
 
 
 
PAIRED SAMPLES TEST 
  
 
  
 
  t df Sig. (2-tailed) 
Pair 1 HAEMOGLOBIN PRE – HAEMOGLOBIN 
POST 
8.469 99 .000 
 
 
 
 
 
 
  
PAIN SCORE 
TABLE 9 
 
MVA/CURE
TTAGE 
N Mean Std. Deviation Std. Error Mean 
pain/VAS 1 100 3.76 1.700 .170 
2 100 5.22 1.133 .113 
This table compares the pain score in both cases and controls. 
INDEPENDENT SAMPLES TEST 
  Levene's Test for Equality of 
Variances t-test for Equality of Means 
  F Sig. t df 
VAS Equal variances assumed 
5.842 .017 -7.145 198 
Equal variances not 
assumed   -7.145 172.462 
 
pain/VAS 
 Equal variances assumed .000 -1.460 .204 
Equal variances not assumed .000 -1.460 .204 
The P value is .000  which is significant. 
 
 
 
  
INDEPENDENT SAMPLES TEST 
  
t-test for Equality of Means 
  
95% Confidence Interval of the Difference 
  Lower Upper 
pain/VAS Equal variances assumed -1.863 -1.057 
    
Equal variances not assumed -1.863 -1.057 
TABLE 9 
The pain score (according to visual analog scale) is more in controls 
(5.22) than cases (3.76). 
CHART: 9 
 
This bar diagram represents the average pain score in both cases 
and control. 
  
 
GRAVIDITY 
TABLE  10 
S.No Gravidity Cases Control 
1 Primigravida 49 63 
2 Second gravida 37 37 
3 Multi gravida 14 0 
 
This tabular column shows the total number of patients in each 
gravidity index. 
 
CHART 10 
This bar diagram represents the distribution of gravidity in cases and control.
  
7. SUMMARY 
 
In Our study, with a sample size of 100, abortion was induced 
using MVA in all CASES and curettage was the procedure used for 
CONTROLS. The results were compared in terms of anesthesia, 
procedure, and patient morbidity. 
• Out of the 100 patients in cases 89% needed only cervical block 
compared to controls which is 66%. In cases, 11% needed 
intravenous anaesthesia compared to the controls that was 34%. 
The p value is 0.037, which is significant. 
• The mean no of pads used by cases were 3.32 compared to 
controls that used 3.95. The p value is <0.001 which is 
significant. 
• The no of blood transfusion required in cases were 4% compared 
to controls, which was 12%. The p value is <0.037 which is 
significant. 
• In cases the % of patients who had retained products were 12% 
compared to controls which constituted around 42%. The p value 
is <0.000 which is significant.  
  
• The % of patients requiring repeat procedure was 8% in cases 
compared to controls which were 21%. The p value is < 0.009 
which is significant. 
• In cases 9% of patients needed more than 2 days duration of  stay 
compared to  controls 24% .The p value is <0.004 which is 
significant. 
• In controls 12% had cervical laceration compared to cases were 
none of patient had cervical laceration. The p value is <0.000 
which is significant. 
• It was observed that there was decrease in hemoglobin  after the 
procedure in cases compared to controls group. 
• The average pain score in cases were 3.76 compared to controls 
which were 5.22.  
• There is no difference in age group in both cases and controls. 
• The first trimester abortion was more in primigravida in both 
groups. 
 
 
 
 
 
  
8. CONCLUSION 
 
This study done in our hospital compared the efficacy of MVA 
against the  curettage in first trimester incomplete  abortion in terms of 
type of anesthesia needed, procedure done and patient morbidity for one 
year. The results are 
1. Our study showed that, MVA can be done under local anesthesia 
(88%) compared to CURETTAGE which required more of  IV 
anesthesia (34%), also the average pain score was less  (3.76) 
when MVA used compared to CURETTAGE (5.22). 
2. Our study showed that the average no of pads used was 3.32 in 
patients who underwent MVA, compared to the average no of 
pads used in patients who underwent curettage which was 3.92 
which is comparatively higher. Thus concluding the average 
amount of blood loss was more when curettage is used for 
abortion compared to MVA. 
3. Our study showed that the need for blood transfusion is more 
when CURETTAGE (12%) is used for attempting abortion 
compared to MVA (4%). 
4. Our study also showed that the number of patients who had 
retained products was less when MVA was used for inducing  
  
abortion compared to curettage and hence the need for repeat 
procedure was less when MVA is used for inducing abortion. 
5. Comparing the complications in both procedure 12% of patients 
had cervical laceration who underwent curettage which was NIL 
in MVA. Also none of the patients in both procedure had uterine 
perforation. 
6. Our study also showed that the decrease in hemoglobin was less 
when MVA is used as the procedure of choice. 
7. The duration of stay in the hospital was less when MVA is used  
for inducing abortion in first trimester, compared to 
CURETTAGE. 
8. Our study also showed that none of the groups had uterine 
perforation.  
9. Also the duration of procedure was found to be same in both the 
procedures (8-10 min). 
Thus concluding that MVA is comparatively better than 
CURETTAGE  in terms of anesthesia, procedure done, and patient 
morbidity. 
 
 
 
 
 
  
9. PROFORMA 
 
 
Name : 
 
Age: 
 
Occupation: 
 
Social Status: 
 
Address: 
 
Date of admission: 
 
Date of Discharge: 
 
Inpatient number: 
 
History: 
 
Marital History: 
 
Menstrual History: 
 
L.M.P                              E.D.D 
 
Obstetric History: 
 
Past History: 
 
Medical : 
 
Diabetes, Hypertension, Renal disease, Cardiac Disease, Asthma, 
Epilepsy. 
 
Family history: 
 
Personal history: 
 
General examination: 
  
 
Systemic examination: 
 
Cardio vascular system 
 
Respiratory system 
 
Central nervous system 
 
Abdominal examination     
 
Local examination: 
 
Per speculam examination   Bimanual  examination 
 
Pain score  
 
Type of anesthesia: 
No of pads used: 
No of blood transfused: 
If any retained products: 
If procedure repeated: 
Pre operative Hb level: 
Post operative Hb level: 
Duration of stay : 
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S.No Name Gravidity Age Anaesthesia 
Pain Blood Loss Blood 
Transfusion 
Retained 
Products 
Repeat 
Procedure 
Stay in 
Hospital 
cervical 
laceration Hb%  
VAS 
Pads / 
Day  
Pre-
procedure 
post 
procedure 
                                                                                 MVA 
      
1 Alisha 1 21 cervical block 7 6 yes yes yes >2 days yes 8.1 7.7 
2 Runiri 1 21 cervical block 7 6 yes yes yes >2 days yes 8 7.8 
3 Saroja 3 20 cervical block 7 6 yes yes yes >2 days yes 8 7.9 
4 Kalyani 1 23 cervical block 7 6 yes yes yes >2 days no 8.2 7.7 
5 Jameela 1 22 cervical block 7 6 no yes yes >2 days no 8.4 8.4 
6 Mallar 2 19 IV 7 6 no yes yes >2 days no 8.4 8.4 
7 Sathya 2 21 cervical block 7 6 no yes yes >2 days no 8.4 8.4 
8 Pattu 2 24 cervical block 7 6 no yes yes >2 days no 8.4 8.4 
9 Mary 2 27 cervical block 6 6 no yes no >2 days no 8.4 8.4 
10 Babitra 2 23 cervical block 7 6 no yes no <2 days no 8.4 8.4 
11 Rathra 1 26 IV 6 6 no yes no <2 days no 8.4 8.4 
12 Suraari 1 25 cervical block 7 6 no yes no < 2 days no 8.3 8.3 
13 Divya 1 24 cervical block 7 6 no yes no < 2 days no 8.3 8.3 
14 Chitra 1 21 cervical block 7 5 no yes no < 2 days no 8.3 8.3 
15 Ambika 3 19 cervical block 7 6 no yes no < 2 days no 8.3 8.3 
16 Kala 3 16 cervical block 7 6 no yes no < 2 days no 8.3 8.3 
17 Chellamma 3 18 cervical block 7 6 no yes no < 2 days no 8.3 8.3 
18 Devi 3 19 IV 5 5 no yes no < 2 days no 8.3 8.3 
19 Vinodhini 3 23 cervical block 4 5 no no no < 2 days no 8.3 8.3 
20 Poornima 3 21 cervical block 4 5 no no no < 2 days no 8.3 8.3 
21 Nazeema 3 25 cervical block 4 5 no no no < 2 days no 8.3 8.3 
  
22 Anjali 2 27 cervical block 4 3 no no no < 2 days no 8.8 8.7 
23 Sastri 1 28 cervical block 4 3 no no no < 2 days no 8.8 8.7 
24 Vimala 1 21 cervical block 4 3 no no no < 2 days no 8.8 8.7 
25 Banumathi 2 22 cervical block 4 3 no no no <2 days no 8.8 8.7 
26 Selvi 3 23 cervical block 4 3 no no no <2 days no 8.8 8.7 
27 Saradha 1 30 cervical block 4 3 no no no <2 days no 8.8 8.7 
28 Amul 2 29 cervical block 4 3 no no no <2 days no 8.8 8.7 
29 Sangeetha 1 21 IV 4 3 no no no <2 days no 8.8 8.7 
30 Rohini 1 22 cervical block 4 3 no no no <2 days no 8.8 8.7 
31 Dhanalakshmi 2 24 cervical block 4 3 no no no <2 days no 8.8 8.7 
32 Victoria 1 24 cervical block 4 3 no no no <2 days no 8.8 8.7 
33 Mumtaz 3 21 cervical block 4 3 no no no <2 days no 8.8 8.7 
34 Moogambigai 2 22 cervical block 4 3 no no no <2 days no 8.8 8.7 
35 Karpargam 2 23 cervical block 4 3 no no no <2 days no 8.9 9 
36 Bhagya 2 24 cervical block 4 3 no no no <2 days no 8.9 9 
37 Shakila 1 25 cervical block 2 3 no no no <2 days no 8.9 9 
38 Seetha 1 28 cervical block 2 3 no no no <2 days no 8.9 9 
39 Elizabeth 2 29 cervical block 2 3 no no no <2 days no 8.9 8.9 
40 Sujama 3 28 IV 2 3 no no no <2 days no 8.9 8.9 
41 Swathi 1 28 cervical block 2 3 no no no <2 days no 8.9 8.9 
42 Ananthi 1 21 cervical block 2 3 no no no <2 days no 8.9 8.9 
43 Rani 2 27 cervical block 2 3 no no no <2 days no 8.9 8.9 
44 Poorna 2 19 cervical block 2 3 no no no <2 days no 8.9 8.9 
45 Sandhya 2 31 cervical block 4 3 no no no <2 days no 8.9 8.9 
46 Madhiya 2 19 cervical block 2 2 no no no <2 days no 8.9 8.9 
47 Rosika 2 21 IV 2 2 no no no <2 days no 8.9 8.9 
48 Sabiya 2 23 cervical block 2 2 no no no <2 days no 9 8.9 
  
49 Kumudha 1 22 cervical block 2 2 no no no <2 days no 9 8.9 
50 Pushpa 2 30 cervical block 2 2 no no no <2 days no 9 8.9 
51 Lalitha 1 20 cervical block 2 2 no no no <2 days no 9 8.9 
52 Indira 1 20 cervical block 2 2 no no no <2 days no 9 8.9 
53 Faridha 2 21 cervical block 4 2 no no no <2 days no 9 8.9 
54 Diliamma 1 22 cervical block 2 2 no no no <2 days no 9 8.9 
55 Gowri 1 23 IV 2 2 no no no <2 days no 9 8.9 
56 Jamuna 2 24 cervical block 2 2 no no no <2 days no 9 8.9 
57 Varalakhsmi 2 25 cervical block 4 2 no no no <2 days no 9 9 
58 Loganayaki 1 26 cervical block 4 2 no no no <2 days no 9 9 
59 Satya 1 21 cervical block 4 2 no no no <2 days no 9 9 
60 Malliga 2 26 cervical block 4 2 no no no <2 days no 9 9 
61 Annamal 1 27 cervical block 2 2 no no no <2 days no 9 9 
62 Esther 2 28 cervical block 2 2 no no no <2 days no 9 9 
63 Karpargam 3 29 cervical block 2 2 no no no <2 days no 9 9 
64 Sumithra 1 21 cervical block 2 2 no no no <2 days no 9 9 
65 Menaka 2 22 cervical block 4 2 no no no <2 days no 9 9 
66 Jyothi 1 23 cervical block 2 2 no no no <2 days no 9 9 
67 Sudha 2 27 cervical block 4 2 no no no <2 days no 9 9 
68 Mala 1 28 cervical block 4 2 no no no <2 days no 9 9 
69 Nirmala 2 31 IV 4 2 no no no <2 days no 9 9 
70 Banu 1 21 cervical block 4 2 no no no <2 days no 8.4 8.5 
71 Kamala 1 22 cervical block 4 2 no no no <2 days no 8.4 8.5 
72 Crystal 2 23 cervical block 4 3 no no no <2 days no 8.4 8.5 
73 Sunitha 1 24 cervical block 4 3 no no no <2 days no 8.4 8.5 
74 Lakshmi 1 25 cervical block 4 3 no no no <2 days no 8.4 8.5 
75 Kokila 1 27 cervical block 4 3 no no no <2 days no 8.4 8.5 
  
76 Sulochana 1 21 cervical block 4 3 no no no <2 days no 8.4 8.5 
77 Pramila 1 22 cervical block 4 3 no no no <2 days no 8.4 8.4 
78 Malliga 1 23 cervical block 4 3 no no no <2 days no 8.4 8.4 
79 Thilagam 1 24 cervical block 4 3 no no no <2 days no 8.4 8.4 
80 Ranju 1 25 cervical block 4 3 no no no <2 days no 8.4 8.4 
81 Beevi 2 26 cervical block 4 3 no no no <2 days no 8.4 8.4 
82 Saroja 1 19 IV 4 3 no no no <2 days no 8.7 8.6 
83 Deivam 1 20 cervical block 4 3 no no no <2 days no 8.7 8.6 
84 Sumathy 1 21 cervical block 4 3 no no no <2 days no 8.7 8.6 
85 Noorjahan 1 22 cervical block 4 3 no no no <2 days no 8.7 8.6 
86 Vennilla 3 21 cervical block 4 3 no no no <2 days no 8.7 8.6 
87 Kartika 3 29 cervical block 2 3 no no no <2 days no 8.7 8.6 
88 Bhavani 2 26 cervical block 2 3 no no no <2 days no 8.7 8.6 
89 Gayathri 2 25 cervical block 2 3 no no no <2 days no 8.7 8.6 
90 Amala 1 24 cervical block 2 3 no no no <2 days no 8.7 8.6 
91 Amudha 2 21 IV 2 3 no no no <2 days no 8.7 8.6 
92 Nalini 1 22 cervical block 2 3 no no no <2 days no 8.7 8.6 
93 Anitha 1 23 cervical block 2 3 no no no <2 days no 8.7 8.6 
94 Valli 1 24 cervical block 2 3 no no no <2 days no 8.7 8.6 
95 Nithya 1 25 cervical block 2 3 no no no <2 days no 8.7 8.6 
96 Prema 1 26 cervical block 2 3 no no no <2 days no 8.7 8.6 
97 Anjammal 2 27 cervical block 2 3 no no no <2 days no 8.7 8.6 
98 Meena 2 28 cervical block 2 3 no no no <2 days no 8.7 8.6 
99 Sharmila 2 29 cervical block 2 3 no no no <2 days no 8.7 8.6 
100 Princy 2 30 IV 2 3 no   no <2 days no 8.7 8.6 
 
 
      
  
                                                                              CURETTAGE 
101 Sangu Lakshmi 1 20 IV 4 5 yes yes yes >2 days yes 8.1 7.9 
102 Poornima 1 21 cervical block 4 5 yes yes yes >2 days yes 8.1 7.8 
103 Vimala 2 22 cervical block 2 5 yes yes yes >2 days yes 8 7.8 
104 Salma 1 23 cervical block 2 5 yes yes yes >2 days yes 8 7.9 
105 Yasmin 1 24 IV 4 5 yes yes yes >2 days yes 8 7.5 
106 Sangeetha 2 26 cervical block 4 5 yes yes yes >2 days yes 8 7.5 
107 Kanchana 1 27 cervical block 2 5 yes yes yes >2 days yes 8.1 7.9 
108 Dorathy 1 25 IV 4 5 yes yes yes >2 days yes 8.1 7.9 
109 Afrin 2 24 cervical block 2 5 yes yes yes >2 days yes 8.1 7.9 
110 Banu Priya 1 22 cervical block 4 5 yes yes yes >2 days yes 8.2 7.8 
111 Saranya 2 21 IV 4 5 yes yes yes >2 days yes 8.1 7.8 
112 Neelavathy 1 24 cervical block 4 5 yes yes yes >2 days yes 8 7.8 
113 Malathy 2 25 IV 4 5 no yes yes >2 days no 8.5 8.6 
114 Kamatchi 1 26 cervical block 4 6 no yes yes >2 days no 8.5 8.6 
115 Renuka Devi 2 27 cervical block 4 6 no yes yes >2 days no 8.5 8.6 
116 Kamatchi 1 28 cervical block 4 6 no yes yes >2 days no 8.5 8.5 
117 Suriya 2 29 cervical block 4 6 no yes yes >2 days no 8.5 8.5 
118 Maha Lakshmi 1 21 IV 4 6 no yes yes >2 days no 8.5 8.5 
119 Parimala 2 20 cervical block 4 6 no yes yes >2 days no 8.5 8.4 
120 Anjalai 1 20 cervical block 4 6 no yes yes >2 days no 8.6 8.4 
121 Flora 1 20 cervical block 4 6 no yes yes >2 days no 8.6 8.4 
122 Kalaivani 1 21 cervical block 4 6 no yes no >2 days no 8.6 8.4 
123 Chitra 1 22 cervical block 4 6 no yes no >2 days no 8.6 8.7 
124 Suganya 2 23 IV 4 6 no yes no >2 days no 8.6 8.7 
125 Samundeeswari 1 30 cervical block 4 6 no yes no <2 days no 8.6 8.6 
126 Yamuna 2 21 IV 4 6 no yes no <2 days no 8.6 8.8 
  
127 Girija  1 22 cervical block 4 6 no yes no <2 days no 8.6 8.8 
128 Kokila Priya 2 22 cervical block 4 6 no yes no <2 days no 8.6 8.8 
129 Supriya 1 21 cervical block 4 6 no yes no <2 days no 8.6 8.5 
130 Vinodha 1 25 cervical block 4 6 no yes no <2 days no 8.6 8.5 
131 Deviga 2 23 IV 4 6 no yes no <2 days no 8.6 8.5 
132 Leela 1 21 cervical block 4 6 no yes no <2 days no 8.8 8.7 
133 Nadhiya 2 23 cervical block 4 6 no yes no <2 days no 8.8 8.7 
134 Sakthi Priya 1 24 cervical block 4 6 no yes no <2 days no 8.8 8.7 
135 Nandhini 1 25 IV 4 3 no yes no <2 days no 8.8 8.7 
136 Geetha 2 26 IV 6 3 no yes no <2 days no 8.8 8.7 
137 Prashathi 2 23 IV 6 3 no yes no <2 days no 8.8 8.7 
138 Selvi Saravanan 1 22 IV 6 3 no yes no <2 days no 8.8 8.7 
139 Muthu Lakshmi 1 21 cervical block 6 3 no yes no <2 days no 8.8 8.7 
140 Mohana Krishni 1 21 cervical block 6 3 no yes no <2 days no 8.8 8.7 
141 Shreema 1 22 cervical block 6 3 no yes no <2 days no 8.8 8.7 
142 Lakshmi 1 21 IV 6 3 no yes no <2 days no 8.8 8.7 
143 Suji 1 22 cervical block 6 3 no no no <2 days no 8.8 8.7 
144 Varalakshmi 1 24 cervical block 6 3 no no no <2 days no 8.8 8.7 
145 Akila 2 23 IV 6 3 no no no <2 days no 8.8 8.7 
146 Kala 1 25 IV 6 3 no no no <2 days no 8.8 8.7 
147 Ramya 2 26 IV 6 3 no no no <2 days no 8.9 8.7 
148 Ruma Biswas 1 27 cervical block 6 3 no no no <2 days no 8.9 8.7 
149 Devi 2 22 cervical block 6 3 no no no <2 days no 8.9 9 
150 Kalaivani 2 21 cervical block 6 3 no no no <2 days no 8.9 9 
151 Mahalakshmi 1 20 cervical block 6 4 no no no <2 days no 8.9 9 
152 Jotheeswari 1 21 cervical block 6 4 no no no <2 days no 8.9 9 
153 Devi 1 21 IV 6 4 no no no <2 days no 8.9 8.6 
  
154 Esther Mary 1 21 cervical block 6 4 no no no <2 days no 8.9 8.6 
155 Premavathy 1 20 cervical block 6 4 no no no <2 days no 8.9 8.6 
156 Jeenath Nisha 1 19 IV 6 4 no no no <2 days no 8.9 9 
157 Kamala 1 23 IV 6 4 no no no <2 days no 8.9 9 
158 Lalitha Kumari 1 24 cervical block 6 3 no no no <2 days no 8.9 9 
159 Swaytha 1 25 cervical block 6 3 no no no <2 days no 8.9 9.1 
160 Sarala 1 21 cervical block 6 3 no no no <2 days no 9.2 9 
161 Devi Bala 1 22 IV 6 3 no no no <2 days no 9.2 9 
162 Kalai Arasi 1 19 cervical block 6 3 no no no <2 days no 9.2 9 
163 Kalaichelvi 2 23 cervical block 6 3 no no no <2 days no 9.2 9 
164 Kaliammal 2 22 cervical block 6 3 no no no <2 days no 9.2 9 
165 Anita 2 21 cervical block 6 3 no no no <2 days no 9.2 9 
166 Sridevi 1 24 IV 6 3 no no no <2 days no 9.2 9 
167 Gomathi 1 25 cervical block 6 3 no no no <2 days no 9.2 9.1 
168 Ramya Chitra 2 26 cervical block 6 3 no no no <2 days no 9.1 9.1 
169 Deepa 1 29 IV 6 3 no no no <2 days no 9.1 9.1 
170 Subhashini 2 21 cervical block 6 3 no no no <2 days no 9.1 9.1 
171 Damayanthi 1 20 IV 6 3 no no no <2 days no 9.1 9.1 
172 Thilaka 2 21 IV 6 3 no no no <2 days no 9.1 9.1 
173 Dhivya 1 22 cervical block 6 3 no no no <2 days no 9.1 8.8 
174 Manju 2 23 cervical block 6 3 no no no <2 days no 9.1 8.8 
175 Madhu 1 24 cervical block 6 3 no no no <2 days no 9.1 8.8 
176 Vasantha 2 25 cervical block 6 3 no no no <2 days no 9.1 8.8 
177 Rajammal 1 22 cervical block 6 3 no no no <2 days no 9.1 9 
178 Kokila 2 21 IV 6 3 no no no <2 days no 9.3 9 
179 Kanmani 1 22 IV 6 3 no no no <2 days no 9.3 9 
180 Nilambari 2 23 IV 6 3 no no no <2 days no 9.3 9 
  
 
181 Muthu Kumari 1 24 cervical block 6 4 no no no <2 days no 9.3 9.1 
182 Muthathal 2 25 cervical block 6 3 no no no <2 days no 9.3 9.1 
183 Jainirmala 1 26 cervical block 6 2 no no no <2 days no 9.3 9.1 
184 Asha 2 22 IV 6 2 no no no <2 days no 9.3 9.1 
185 Shameem 1 21 IV 6 3 no no no <2 days no 9.3 9.1 
186 Fathima 2 22 cervical block 6 3 no no no <2 days no 9.3 9.1 
187 Aisha Behgam 1 21 cervical block 6 3 no no no <2 days no 9.3 9.1 
188 Saritha 2 20 IV 6 3 no no no <2 days no 8.9 8.8 
189 Shanthi 1 25 cervical block 6 3 no no no <2 days no 8.9 8.8 
190 Rajalakshmi 2 27 cervical block 6 3 no no no <2 days no 8.9 8.8 
191 Rajeshwari 1 23 IV 6 3 no no no <2 days no 8.9 8.7 
192 Kirthika 1 22 cervical block 6 3 no no no <2 days no 8.9 8.7 
193 Keerthana 2 28 cervical block 6 3 no no no <2 days no 8.9 8.7 
194 Latha 1 27 IV 6 3 no no no <2 days no 8.9 8.7 
195 Anjali 1 26 cervical block 6 3 no no no <2 days no 8.9 8.7 
196 Preethi 2 21 cervical block 6 3 no no no <2 days no 8.9 8.8 
197 Sanghavi 1 21 IV 6 3 no no no <2 days no 8.9 8.8 
198 Lalitha 2 22 cervical block 6 3 no no no <2 days no 8.9 8.6 
199 Parvathi 1 23 cervical block 6 3 no no no <2 days no 8.9 8.7 
200 Punitha 1 28 cervical block 6 3 no no no <2 days no 8.9 8.7 
 
             
